Right to Choose is your legal right — but your GP still has to agree a referral is clinically appropriate, and some ICBs now add a local triage step. Evidence removes the hesitation. That is where we come in. Our qEEG brain screening provides objective neurological data — measured brain activity, not questionnaire scores — that gives GPs the clinical confidence to submit the referral. Same-day report. Clinical letter included with comprehensive package.
Source: NHS England ICB commissioning data · ADHD UK postcode tracker
The NHS body responsible for ADHD assessment commissioning around Stockport is NHS Greater Manchester ICB. Wait times for the standard pathway vary significantly between trusts inside the same ICB, and published figures often lag reality — which is why we recommend checking current reported waits via ADHD UK before deciding your route.
One development worth knowing: some ICBs have begun triaging or restricting Right to Choose ADHD referrals, and GP practices do not always distinguish between local ICB guidance and your national legal rights. If your GP near Stockport says 'we cannot do Right to Choose here,' the correct response is to ask whether that is NHS Greater Manchester ICB policy in writing, and what the approved local pathway is. In most cases the referral can still proceed — it may simply route differently. Our clinical letter names the pathway explicitly, which removes most of this friction.
Women and girls across Greater Manchester are systematically underdiagnosed. ADHD diagnostic criteria were historically developed from studies of hyperactive boys. Women typically present with the inattentive subtype — quiet, internal, masked by socialisation. Many are told it is anxiety, depression, or personality. By the time they reach a GP near Stockport, they have often been dismissed multiple times.
Right to Choose offers a route to specialist assessment where the clinician understands how ADHD presents in women. But the GP gatekeeping remains. A woman who 'seems fine' in a 10-minute appointment is unlikely to get a referral based on self-report alone. Objective brain data changes this equation entirely. Our qEEG screening measures cortical electrical activity directly — it does not care about socialised masking behaviour. Elevated theta/beta ratio is elevated theta/beta ratio, regardless of how composed you appear in the GP's office.
Our ADHD in women guide covers the hormonal interactions, masking, and diagnostic bias that make this particularly important.
Shared care is the arrangement where a specialist prescribes and stabilises ADHD medication, then transfers ongoing prescribing to your GP. This is how ADHD medication is managed long-term in the UK — the specialist handles initiation and titration, the GP handles repeat prescriptions and monitoring.
Most GPs near Stockport accept shared care from established Right to Choose providers. The key factors are: the diagnosing clinician is GMC-registered, the assessment meets NICE NG87 standards, the provider is CQC-registered, and the shared care protocol is clear and well-documented. Psychiatry-UK has formal shared care agreements accepted by the vast majority of GP practices.
In the small number of cases where a GP declines shared care, options include: requesting a different GP at the same practice, registering with a different practice, or the diagnosing provider continuing to prescribe privately while you pursue resolution. This is rare but our next steps guide covers it in detail.
The pathway from Stockport to diagnosis runs through five clear stages. First, evidence gathering: our brain screening provides the objective data, but you should also complete an ASRS-v1.1 (adults) or Conners questionnaire (children), write a functional impairment summary, and gather any historical evidence (school reports, previous assessments).
Second, the GP appointment: book a double slot, present everything in the first minute, and make the Right to Choose request explicitly. Our GP evidence guide has word-for-word scripts. Third, the referral itself: a 5-minute administrative process if the GP has the evidence in front of them. Fourth, the wait: 3–6 months typically, during which you can use the screening report for school, work, and other support. Fifth, the assessment: comprehensive clinical evaluation following NICE NG87, leading to diagnosis and treatment if appropriate.
Most clients near Stockport complete steps 1–3 within two weeks. The total elapsed time from brain screening to diagnosis is typically 4–8 months — compared to 3–7 years via the standard NHS pathway.
Objective brain data does three things that self-report cannot. First, it removes the bias inherent in questionnaires — particularly important for women who mask, adults who have developed sophisticated coping strategies, and children who behave differently in clinic than in the classroom. Second, it provides a quantified measurement expressed as a z-score — a language every clinician understands instantly. Third, it gives the GP a defensible clinical basis for the referral — something they can point to in the patient record that justifies the decision.
Multiple clients from Stockport have reported that presenting the clinical letter to their GP resulted in an immediate shift in the conversation. GPs who had previously said 'let's wait and see' or 'try these coping strategies first' moved directly to submitting the Right to Choose referral once they saw the objective neurological data.
Objective z-scores and peer-reviewed citations are significantly harder to dismiss than self-reported symptoms. GPs near Stockport respond to evidence.
GPs who include our data in their referral letter give the receiving provider more context, leading to a more focused and efficient assessment.
During the 3–6 month wait, use the report for EHCP applications, Access to Work, and employer reasonable adjustments.
If diagnosed, your baseline data enables a follow-up comparison scan (£345) to objectively track medication response.
Brain screening (£595–£845) + Right to Choose (free) + shared care (NHS). Total: under £850 for a complete diagnostic pathway.
The Right to Choose assessor reviews all evidence. Objective brain data adds a dimension that no other patient typically brings to the assessment.
A third option is fully private assessment (£700–£1,500), which has the shortest wait (2–8 weeks) but you pay the full cost. Many people from Stockport combine approaches: brain screening (£595–£845) + Right to Choose assessment (free) + Access to Work support (free). Total out-of-pocket: the screening only. View all pricing options.
We provide Right to Choose evidence for children aged 6+, teenagers, adults, and women & girls who are systematically underdiagnosed by questionnaire-based assessment.
Each person is compared against age-matched normative data from published research. The clinical letter is tailored for Right to Choose referral submissions, with z-scores, peer-reviewed citations, and specific recommendations your GP can act on immediately.
View packages: standard screening (£595) · comprehensive (£845) · family package (£1,095) · all pricing
After your screening: ADHD support hub · results explained · what to do next · GP appointment guide · medication guide · coping strategies · workplace rights · ADHD in women · parent's guide · relationships guide · sleep guide · exercise & ADHD
GP referrals from Stockport are commissioned by NHS Greater Manchester ICB. Right to Choose is national law, but since 2024 several ICBs have introduced triage steps or attempted restrictions on ADHD Right to Choose referrals, and the position changes frequently. Before your GP appointment, check the current position on the ICB's own website and via ADHD UK's local data pages — so you can ask for the correct pathway by name.
Yes — and you should. While waiting for Right to Choose assessment, use the report for: EHCP applications, JCQ exam access arrangements, Access to Work evidence, employer reasonable adjustments, and additional GP conversations. One screening supports multiple applications simultaneously.
Request the refusal in writing. Ask for a second opinion from another GP at the same practice. Consider registering with a different practice. Contact PALS (Patient Advice and Liaison Service). Ask Psychiatry-UK to contact the GP directly — they have a process for this. GP refusal after seeing objective brain data is rare but not impossible.
Yes. The assessment is fully NHS-funded — you pay nothing for the assessment itself. The only cost is any supporting evidence you choose to gather beforehand, such as our brain screening (£595–£845). Everything from the Right to Choose referral onwards is free.
Right to Choose is a legal right under the NHS Constitution — your GP cannot remove the right itself, but they can decline to refer for ADHD if they believe it is not clinically warranted, and some ICBs have added local triage steps that change how referrals route. Objective brain data makes a clinical refusal very difficult to justify. If your GP declines, ask for the reason in writing, ask what the ICB's current approved pathway is, and request a second opinion.
Yes. Right to Choose applies to children and teenagers as well as adults. Parents request the referral through their child's GP. The family package (£1,095) screens two family members for Right to Choose evidence.
Typically 3–6 months from GP referral to assessment. This varies by provider and current demand. Even at the longer end, it is dramatically faster than the 2–5 year Greater Manchester NHS standard pathway. During the wait, your screening report supports school, work, and other applications.
Yes. The two pathways run in parallel. Stay on the NHS list as backup while pursuing Right to Choose as a faster route. If assessed via Right to Choose first, you can then leave the NHS list. We recommend staying on both.
If ADHD is confirmed, the provider initiates medication (typically stimulant or non-stimulant options) and monitors your titration over 4–12 weeks. They then set up a shared care agreement with your GP for ongoing prescribing. Your GP handles repeat prescriptions at standard NHS cost (£9.90 per item or free with prepayment).
Not required — but strongly recommended. Our clinical letter provides the objective evidence that convinces GPs to refer. Without it, many GPs hesitate. With it, most refer promptly. The comprehensive package (£845) includes the clinical letter specifically formatted for Right to Choose referrals.
The Comprehensive Assessment (£845) — it includes the clinical interpretation letter your GP needs, tailored for Right to Choose referral submissions. The standard Brain Screening (£595) provides the data report but without the formal letter.
Share this page with someone waiting for an ADHD assessment.
Same-day clinical letter. Evidence your GP will act on. From £595.